Liver transplantation for hepatocellular carcinoma: pre-transplant considerations and post-transplant management
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
The three-model screen
all 1,000 screened works →All three models called this out of scope.
Clinical review of liver transplantation for hepatocellular carcinoma.
This is a clinical review of liver transplantation for hepatocellular carcinoma, not a review of research methods.
Clinical review of liver transplantation for hepatocellular carcinoma management.
Abstract
Hepatocellular cancer is the seventh most frequent and third leading cause of cancer death worldwide. At its early stages, it could be amenable to complete cure using surgical resection or ablative therapies. Unfortunately, some patients present with advanced tumor stages or have reduced liver function and locoregional therapies may not be used or effective. Liver transplantation becomes an appealing option as it replaces the ailing liver and offers a chance for complete cure. Outcomes of liver transplantation for hepatocellular cancer have improved with better patient selection and adjuvant therapies allow patients to become eligible for transplantation and minimize dropouts from the waiting list. Post-transplant care, including appropriate surveillance and immunosuppression can also improve long-term outcomes with survival similar to transplantation for non-oncologic indications.
Stored with the screening record, where it is evidence for the labels above.
The record
- Venue
- AME Medical Journal
- Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Field
- Medicine
- Canadian institutions
- University of British Columbia
- Funders
- —
- Keywords
- MedicineHepatocellular carcinomaImmunosuppressionLiver transplantationTransplantationMilan criteriaSurgeryAdjuvantLiver cancerCancerIntensive care medicineOncologyInternal medicine
- Has abstract in OpenAlex
- yes